Terminal · Institutions

Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.

JAY JEFFREY R 13F Holdings -- Portfolio & Top Positions (2013-06-30)

JAY JEFFREY R (CIK 1239607) reported $126.5M across 27 reported positions in its SEC 13F filing for 2013-06-30. Largest positions: HPTX ($21.2M, 16.76%), FURX ($16.8M, 13.30%), STML ($14.2M, 11.22%), ALBO ($7.7M, 6.12%), ($7.0M, 5.53%). Source: SEC Form 13F.

RankTickerCompanyValue% PortfolioSharesAction
1HPTXHYPERION THERAPEUTICS INC.$21.2M16.76%963,961New
2FURXFURIEX PHARMACEUTICAL, INC.$16.8M13.30%494,100New
3STMLSTEMLINE THERAPEUTICS INC.$14.2M11.22%595,493New
4ALBOBIODEL INC.$7.7M6.12%1.9MNew
5AMBIT BIOSCIENCES CORP$7.0M5.53%1.0MNew
6GERNGERON CORPORATION$5.6M4.45%3.8MNew
7SAVAPAIN THERAPEUTICS INC.$5.1M4.06%2.3MNew
8NUWESUNSHINE HEART INC.$5.1M4.03%950,000New
9DRTXDURATA THERAPEUTICS INC.$4.6M3.64%639,433New
10NORDION INC.$4.0M3.14%537,500New
11HZNPHORIZON PHARMA, INC.$3.9M3.10%1.6MNew
12ACHVONCOGENEX PHARMACEUTICAL INC.$3.4M2.69%347,004New
13IPXLIMPAX LABORATORIES, INC.$3.0M2.36%150,000New
14TRIBTRINITY BIOTECH PLC$2.7M2.17%163,140New
15SRGARTI BIOLOGICS, INC.$2.5M2.00%673,898New
16DYAXDYAX CORP$2.5M1.99%728,063New
17MSTXMAST THERAPEUTICS INC.$2.5M1.97%5.8MNew
18PLXPROTALIX BIOTHERAPEUTICS INC.$2.0M1.55%399,007New
19MYGNMYRIAD GENETICS INC.$1.9M1.49%70,000New
20VOLCVOLCANO CORPORATION$1.8M1.43%100,000New
21CBIOTARGACEPT, INC.$1.6M1.24%367,709New
22AVNRAVANIR PHARMACEUTICALS INC.$1.2M0.94%258,600New
23XNPTXENOPORT INC.$1.2M0.91%232,977New
24MEIPMEI PHARMA INC.$1.1M0.89%157,661New
25PTXTQPERNIX THERAPEUTICS HOLDINGS$1.1M0.85%297,187New

Source: SEC Form 13F filings · as of 2013-06-30